Royal Bank of Canada’s THERATECHNOLOGIES INC COM THER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-17,079
Closed -$14K 8009
2023
Q2
$14K Buy
17,079
+149
+0.9% +$122 ﹤0.01% 6367
2023
Q1
$13K Sell
16,930
-1,833
-10% -$1.41K ﹤0.01% 6219
2022
Q4
$16K Buy
18,763
+1,960
+12% +$1.67K ﹤0.01% 6395
2022
Q3
$40K Buy
16,803
+815
+5% +$1.94K ﹤0.01% 5852
2022
Q2
$36K Sell
15,988
-8,039
-33% -$18.1K ﹤0.01% 5866
2022
Q1
$59K Sell
24,027
-2,653
-10% -$6.51K ﹤0.01% 5991
2021
Q4
$81K Buy
26,680
+4,462
+20% +$13.5K ﹤0.01% 6087
2021
Q3
$83K Sell
22,218
-248
-1% -$926 ﹤0.01% 5840
2021
Q2
$87K Buy
22,466
+248
+1% +$960 ﹤0.01% 5705
2021
Q1
$85K Buy
22,218
+3,790
+21% +$14.5K ﹤0.01% 5571
2020
Q4
$46K Sell
18,428
-1,800
-9% -$4.49K ﹤0.01% 5699
2020
Q3
$44K Sell
20,228
-1,364
-6% -$2.97K ﹤0.01% 5403
2020
Q2
$43K Sell
21,592
-52,821
-71% -$105K ﹤0.01% 5301
2020
Q1
$119K Sell
74,413
-6,046
-8% -$9.67K ﹤0.01% 4670
2019
Q4
$265K Buy
+80,459
New +$265K ﹤0.01% 4442

Other funds holding THER

Royal Bank of Canada's THER Position: Q3 2023 in Review

Royal Bank of Canada sold out of THERATECHNOLOGIES INC COM (THER) in Q3 2023, closing a stake of 17,079 shares — an estimated $14K sold.

Royal Bank of Canada first reported a position in THER in Q4 2019 and held it in 15 quarters. The position peaked at $265K in Q4 2019. 2 funds tracked by Wall St. Rank hold THER as of Q3 2023.

  • Royal Bank of Canada reported no remaining THERATECHNOLOGIES INC COM position as of Q3 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 17,079 THERATECHNOLOGIES INC COM shares in Q3 2023, an estimated $14K.
  • Royal Bank of Canada first reported a position in THERATECHNOLOGIES INC COM in Q4 2019 and held it in 15 quarters.
  • Royal Bank of Canada's THERATECHNOLOGIES INC COM position peaked at $265K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held THERATECHNOLOGIES INC COM as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.